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pioneers like Pearl Kendrick, Margaret Pittman,
L B Holt, and members of the WHO group, and I
gave relevant references. If Dr Preston objects, he
should refute their work not mine. He might also
take issue with Dr Griffith, who says (and I do not
doubt it) that his company's vaccine contained all
the main antigens from 1964 or earlier. Addition of
antigen 3 to all British vaccines did not stop the
major outbreaks of 1967-8, 1970-1, or 1974-5
during a period when vaccine acceptance was much
higher than it is now; nor did it bring any change
in the fact that 25-35%,' of proved cases, now as well
as then, occur in fully vaccinated children not only
in Britain but also in the United States,' Canada,2
Australia,3 Sweden,4 and elsewhere. In parts of
Scotland in 1977-9 the incidence of whooping
cough in fully vaccinated children exceeded this
range,5 6 and it could be argued that the loss of
immunity two to three years after vaccination is the
main determinant of the otherwise unexplained
44 month periodicity of outbreaks of whooping
cough in Britain (personal report to Department of
Health and Social Security).
I imagine that most of your readers are
bored, confused, or exasperated by the con-
tinuing controversy about this one, relatively
unimportant infection and its relatively
ineffective vaccine, which is disproportionately
important because so many children receive it.
Might I therefore state yet again the central
plea in my own argument for the need to
repair ."the national deficit in epidemio-
logical data and intelligence,"5 because without
some improvement, and not only about pertus-
sis vaccine, we are abusing the trust of the
public in medical judgment and in medica-
ments.
GORDON T STEWART
University Department of
Community Medicine,
Ruchill Hospital,
Glasgow G20 9NB
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Effects of pirbuterol and sodium
nitroprusside on pulmonary
haemodynamics in hypoxic cor
pulmonale
SIR,-I would like to take issue with the
methodology used by Dr W MacNee and
others (22 October, p 1169) for measurement
of pulmonary vascular resistance and the
effects on this variable of the two drugs
pirbuterol and sodium nitroprusside.
The authors state: "Left atrial pressure is
not always easy to assess from pulmonary
artery wedge pressure in these patients." The
formula for measuring pulmonary vascular
resistance is therefore invalid, as it includes no
estimate of the pressure difference across the
pulmonary circuit. Whether one believes in the
concept of "resistance" in the pulmonary
circuit or "impedance," I am sure that most
workers would argue that the formula used in
this study was wrong.1 2
Furthermore, it is not valid to assume that
long term administration of pirbuterol had
beneficial effects, when no estimate is made of
cardiac output. Thus a reduction purely in
systolic pressure does not seem clinically
important in the pulmonary circuit when there
is no estimate of flow through it.
D W GREEN
King's College Hospital,
London SE5 9RS
Foex P. Pulmonary dynamics. In: Prys-Roberts C, ed.
The circulation in anaesthesia. Oxford: Blackwell
Scientific Publications, 1980:258-9.
2 Kaplan JA. Immunodynamic monitoring. In: Kaplan
JA, ed. Cardiac anaesthesia. New York: Grune
and Stratton, 1979-95.
***The authors reply below.-ED, BM7.
SIR,-Dr D W Green is, of course, technically
correct. In any segment of the circulation the
resistance is defined as the drop in pressure
across the segment divided by the rate of
volume flow through it. Thus the pulmonary
vascular resistance is expressed as the differ-
ence between the mean pulmonary arterial
pressure and the mean left atrial pressure
divided by the cardiac output.
In stating this, however, Dr Green has
ignored the controversy that has existed for the
past 20 years or more as to whether measure-
ment of pulmonary capillary wedge pressure
accurately reflects mean left atrial pressure in
patients with severe chronic bronchitis and
emphysema, such as those studied in our
paper. Fishman states: "Pulmonary capillary
wedge pressure and pulmonary diastolic pres-
sure are unreliable indexes of left atrial
pressure" in such patients as "either veno-
constriction or anatomic change in the inter-
vening vessels may invalidate these measure-
ments."' Recent authors support the view that
the measurement of pulmonary capillary
wedge pressure should be interpreted with
caution in patients with disordered pulmonary
mechanics,2 and in such patients "a simple
mean of the wedge pressure can be raised sec-
ondary to positive intrathoracic pressure dur-
ing expiration."3 Although Lockhart has not
ascribed the rises in pulmonary capillary
wedge pressure in patients with obstructive
lung disease to a generalised rise of intra-
thoracic pressure, close scrutiny of this paper
(fig 4) shows a variability of 5 mm Hg between
pulmonary capillary wedge pressure and left
ventricular end diastolic pressure measured at
rest.4
It is for these reasons that we chose to
measure total pulmonary vascular resistance, so
avoiding the effect of a possible error in the
measurement of resistance. As pulmonary
artery pressure in our patients was high and we
have assumed that left atrial pressure was low
(as all of our patients had well preserved left
ventricular function) this is not dissimilar to
the approach in calculating systemic vascular
resistance, where the right atrial pressure is not
usually considered. It was for similar reasons
that total pulmonary vascular resistance was
measured in the MRC long term domiciliary
oxygen trial5 and that the largest single series
of measurements of pulmonary haemo-
dynamics in patients with obstructive lung
disease does not mention measurements of
pulmonary capillary wedge pressure.6 We
cannot therefore agree with Dr Green that
"most workers would argue that the formula
we used in this study was wrong." We have
defined total pulmonary vascular resistance
(kPa s/cm5) as the mean pulmonary artery
pressure divided by the cardiac output times
8-a definition used by many other
workers.7
We would also point out that the beneficial
effects oflong term administration ofpirbuterol
were based on a reduction of systolic pulmon-
ary artery pressure and an increase in right
ventricular ejection fraction. Cardiac output
was not measured in order to reduce the
number of invasive measurements made
during the chronic study. As the increase in
right ventricular ejection fraction paralleled
the increase in cardiac output during the acute
study and as a consistent increase in right
ventricular ejection fraction occurred in the
chronic study, we have assumed that cardiac
output would also increase.
W MAcNEE
A L MUIR
D C FLENLEY
Departments of Respiratory
Medicine and Medicine,
University of Edinburgh,
Edinburgh EH10 5SB
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Recognising placental steroid sulphatase
deficiency
SIR,-The determination of the steroid
sulphatase activity in leucocyte homogenates
(23 July, p 293)1 certainly meets the demand
for an "easy diagnostic method for X-linked
ichthyosis suitable for routine clinical bio-
chemistry laboratories" put forward in the
leading article by Dr R A Harkness and others
(2 July, p 2). Unfortunately, we observed a
considerable variation of the steroid sulphatase
activity among obligate carriers of the steroid
sulphatase deficiency trait. This limits the
ability of our simple method' to recognise
heterozygotes, which can be needed urgently
in cases of low urinary steroid excretion
during pregnancy as this may be caused by
steroid sulphatase deficiency.
The results of the steroid sulphatase activity
determination proved the heterozygosity for
this trait in only 14 out of 18 carriers (figure).
The much greater variation in the carrier
group than in the healthy normal group is not
likely to be due to technical differences, as all
assays were carried out in the same period by
one person.
Scientifically, these results are most in-
teresting as they indicate that no complete
escape from X-chromosomal inactivation of the
steroid sulphatase locus seems to occur in
leucocytes. This, however, differs from the
results with cultured fibroblasts initially
reported by Shapiro et al for four obligate
carriers3 and reported by Muller et al for five
obligate carriers,4 which suggested complete
escape of inactivation. The reported steroid
sulphatase activity in leucocytes5 and in
lymphocytes6 of normal persons and further
work of Shapiro's group on cultured fibro-
blasts from carriers of the steroid sulphatase
deficiency trait7 indicate, though, a differential
expression of the steroid sulphatase locus.
